Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tempus Fugit.

Murphy1

  • 1AlphaMed Press, Miamisburg, Ohio, 45342-3758, USA. mjm@alphamedpress.com

The Oncologist
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

The Oncologist journal provides practicing physicians with authoritative interpretations of cancer data. It features diverse articles on adult and pediatric cancer care, clinical trials, and alternative treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rules for the Administration of Chloroform in Labor.

Iowa medical journal·2023
Same author

On Certain Forms of Headache.

The North-Western medical and surgical journal·2023
Same author

Twins Locked in Each Other.

The North-Western medical and surgical journal·2023
Same author

Report on the Use of Apomorphia in Sunstroke.

The Indian medical gazette·2017
Same author

Pharmacokinetic profile of rectally administered diclofenac sodium in children undergoing adenotonsillectomy

Paediatric anaesthesia·2000
Same author

Protease Inhibitors Therapy for AIDS Patients.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2000
Same journal

Durable Response to Sotorasib in KRAS G12C-Mutant Intrahepatic Cholangiocarcinoma: A Case Report.

The oncologist·2026
Same journal

The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective Study.

The oncologist·2026
Same journal

Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 population.

The oncologist·2026
Same journal

Molecular Tumor Board-Guided Osimertinib Therapy in EGFR L858R/Q701L-Mutant Lung Adenocarcinoma Supported by Functional Validation.

The oncologist·2026
Same journal

Phase 2 Dose Expansion Trial of OBI-3424, a DNA-Alkylating Prodrug, in Patients with Advanced Solid Tumors Expressing AKR1C3.

The oncologist·2026
Same journal

Divergent Biology and Outcomes of Somatic Transformations in Germ Cell Tumors.

The oncologist·2026
See all related articles

Area of Science:

  • Oncology
  • Medical Publishing
  • Clinical Practice

Background:

  • The Oncologist journal was founded to serve busy practicing physicians caring for cancer patients.
  • A key objective is to critically review and publish papers that interpret vast amounts of available medical data.
  • The journal emphasizes interpretation of data over raw data presentation.

Purpose of the Study:

  • To provide authoritative, topical, and innovative articles for practicing oncologists.
  • To critically review and publish papers interpreting complex cancer-related data.
  • To cover a wide range of cancer topics, including adult and pediatric care, clinical trials, and emerging treatments.

Main Methods:

  • Publication of peer-reviewed manuscripts from international authorities.

Related Experiment Videos

  • Inclusion of diverse sections such as 'Meet The Professor', 'Physician Education', and 'Patient Care'.
  • Collaboration with external sources for news and updates relevant to cancer care.

    • Main Results:

    • Publication of over forty manuscripts covering diverse oncology topics.
    • Featured articles on locally advanced breast cancer, thrombopoietin, purine analogs, bone marrow transplantation, lung cancer, esophageal cancer, childhood cancers, and rectal cancer.
    • Introduction of new sections like 'Patient Care' and 'The Oncologist News Bulletin' to enhance reader engagement and information dissemination.

    Conclusions:

    • The Oncologist journal has successfully published a wide array of high-quality, interpretive content in its inaugural year.
    • The journal is committed to addressing both adult and pediatric cancer care, as well as clinical trials and alternative treatments.
    • Feedback from readers is actively sought to further enhance the journal's relevance and fulfill its pledges to the readership.